A 1H‐isoindol‐3‐amine was identified as suitable P1 group for the proprotein convertase furin using a crystallographic screening with a set of 20 fragments known to occupy the S1 pocket of trypsin‐like serine proteases. Its binding mode is very similar to that observed for the P1 group of benzamidine‐derived peptidic furin inhibitors suggesting an aminomethyl substitution of this fragment to obtain a couplable P1 residue for the synthesis of substrate‐analogue furin inhibitors. The obtained inhibitors possess a slightly improved picomolar inhibitory potency compared to their benzamidine‐derived analogues. The crystal structures of two inhibitors in complex with furin revealed that the new P1 group is perfectly suited for incorporation in peptidic furin inhibitors. Selected inhibitors were tested for antiviral activity against respiratory syncytial virus (RSV) and a furin‐dependent influenza A virus (SC35M/H7N7) in A549 human lung cells and demonstrated an efficient inhibition of virus activation and replication at low micromolar or even submicromolar concentrations. First results suggest that the Mas‐related G‐protein coupled receptor GPCR‐X2 could be a potential off‐target for certain benzamidine‐derived furin inhibitors.
The Front Cover shows the crystal structure of a highly potent inhibitor of the proprotein convertase furin containing a C-terminal aminoisoindol group superimposed with a previously developed benzamidine analogue. This new P1 anchor was identified by crystallographic fragment screening with furin and enabled the design of peptidic inhibitors with inhibition constants < 10 pM. The inhibitors showed significant antiviral activity against respiratory syncytial virus and a furin-dependent influenza A virus. More information can be found in the Research Article 202400057 by Roman W. Lange, Sven O. Dahms, Torsten Steinmetzer, and co-workers.